Related Experiment Video
Updated: Apr 20, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
Yue Huang1, Jingli Yan2, Qi Li1
1CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Abstract:
Two human demethylases, the fat mass and obesity-associated (FTO) enzyme and ALKBH5, oxidatively demethylate abundant N(6)-methyladenosine (m(6)A) residues in mRNA. Achieving a method for selective inhibition of FTO over ALKBH5 remains a challenge, however. Here, we have identified meclofenamic acid (MA) as a highly selective inhibitor of FTO. MA is a non-steroidal, anti-inflammatory drug that mechanistic studies indicate competes with FTO binding for the m(6)A-containing nucleic acid. The structure of FTO/MA has revealed much about the inhibitory function of FTO. Our newfound understanding, revealed herein, of the part of the nucleotide recognition lid (NRL) in FTO, for example, has helped elucidate the principles behind the selectivity of FTO over ALKBH5. Treatment of HeLa cells with the ethyl ester form of MA (MA2) has led to elevated levels of m(6)A modification in mRNA. Our collective results highlight the development of functional probes of the FTO enzyme that will (i) enable future biological studies and (ii) pave the way for the rational design of potent and specific inhibitors of FTO for use in medicine.
Insights
Meclofenamic acid selectively inhibits the FTO enzyme, a key player in mRNA demethylation. This discovery offers new tools for studying FTO and developing targeted medical treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Epigenetics
Background:
- N(6)-methyladenosine (m(6)A) is a prevalent mRNA modification.
- FTO and ALKBH5 are human demethylases that remove m(6)A.
- Selective inhibition of FTO over ALKBH5 is a significant challenge.
Purpose of the Study:
- To identify a selective inhibitor of the FTO enzyme.
- To elucidate the mechanism of FTO inhibition.
- To explore the therapeutic potential of FTO inhibitors.
Main Methods:
- Screening for FTO inhibitors.
- Mechanistic studies of inhibitor binding.
- Structural analysis of FTO/inhibitor complex.
- Cell-based assays to assess m(6)A levels.
Main Results:
- Meclofenamic acid (MA) identified as a potent and selective FTO inhibitor.
- MA competes with m(6)A-containing nucleic acids for FTO binding.
- Structural insights into FTO inhibition and selectivity.
- MA treatment increases m(6)A levels in mRNA in HeLa cells.
Conclusions:
- Meclofenamic acid is a valuable chemical probe for FTO.
- Understanding FTO inhibition principles aids in designing future therapeutics.
- Selective FTO inhibition has potential applications in medicine.
More Related Videos
Related Concept Videos
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Drugs that Destabilize Microtubules
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

